CCDC75P1

Across TCGA pan-cancer cohorts, CCDC75P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated CCDC75P1 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher CCDC75P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCDC75P1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUAD show a favorable association.

PAAD, LUSC, and ESCA are the cancer types where CCDC75P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	36	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	36	view →
ESCA	DFS	Tertile	III,IV	0.648	0.314	.001	36	view →
LUAD	DFS	Tertile	II,III,IV	0.714	0.389	.019	33	view →
KICH	DFS	Tertile	All	0.162	0.862	.014	30	view →
LAML	DFS	Quartile	All	0.671	0.314	.002	24	view →
TGCT	DFS	Tertile	All	0.620	0.849	.019	18	view →
READ	DFS	Tertile	III,IV	1.000	0.326	.021	18	view →
SKCM	DFS	Tertile	II,III,IV	0.815	0.533	.011	18	view →
KIRC	DFS	Tertile	III,IV	0.212	0.495	.032	18	view →
DLBC	DFS	Tertile	III,IV	0.070	0.855	.008	18	view →
MESO	OS	Tertile	IV	0.155	0.624	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

CCDC75P1–PAAD (DFS)

Open the PAAD breakdown →